[HTML][HTML] AS03-and MF59-adjuvanted influenza vaccines in children

AL Wilkins, D Kazmin, G Napolitani… - Frontiers in …, 2017 - frontiersin.org
Influenza is a major cause of respiratory disease leading to hospitalization in young
children. However, seasonal trivalent influenza vaccines (TIVs) have been shown to be …

Toxic shock syndrome–the seven Rs of management and treatment

AL Wilkins, AC Steer, PR Smeesters, N Curtis - Journal of Infection, 2017 - Elsevier
Staphylococcal and streptococcal toxic shock syndrome (TSS) are associated with
significant morbidity and mortality. There has been considerable progress in understanding …

Question 1: Is it safe to use ivermectin in children less than five years of age and weighing less than 15 kg?

AL Wilkins, AC Steer, N Cranswick… - Archives of disease in …, 2018 - adc.bmj.com
You are working in a remote clinic in Northern Australia and see an 18-month-old girl
(weight 10 kg) who presents with a pruritic rash on her extremities. She has a history of …

[HTML][HTML] Memory-like innate response to booster vaccination with MF-59 adjuvanted influenza vaccine in children

D Kazmin, EA Clutterbuck, G Napolitani, AL Wilkins… - npj Vaccines, 2023 - nature.com
The pediatric population receives the majority of vaccines globally, yet there is a paucity of
studies on the transcriptional response induced by immunization in this special population …

Individualized vancomycin dosing in infants: prospective evaluation of an online dose calculator

AL Wilkins, T Lai, X Zhu, S Bolisetty, R Chiletti… - International Journal of …, 2023 - Elsevier
Background Empiric vancomycin dosing regimens fail to achieve recommended target
trough concentrations of 10-20 mg/L in the majority of infants. This study assessed the …